Vascular medicine and thrombectomy in stroke

So you have successfully either pulled out or dissolved the clot. But no one is taking any steps to stop all the continuing death of neurons from the 5 causes of the neuronal cascade of death. Stop patting yourself on the back and get back to work.
http://journals.sagepub.com/doi/abs/10.1177/1756285617742082 

Show all authors

Sebastian Fischer

University Hospital of Bochum In der Schornau 23-25, Bochum 44892, Germany
See all articles by this author

Search Google Scholar for this author

, Werner Weber

University Hospital of Bochum, In der Schornau 23-25, Bochum 44892, Germany
See all articles by this author

Search Google Scholar for this author

First Published November 22, 2017 Review Article

https://doi.org/10.1177/1756285617742082

Download PDF	Article information

Article Information

Volume: 11

Article first published online: November 22, 2017; Issue published: January 1, 2018
Received: August 10, 2017; Accepted: September 29, 2017

https://doi.org/10.1177/1756285617742082

Sebastian Fischer

University Hospital of Bochum, In der Schornau 23-25, Bochum 44892, Germany

,

Werner Weber

University Hospital of Bochum, In der Schornau 23-25, Bochum 44892, Germany

Werner.weber@kk-bochum.de

Corresponding Author: Werner.weber@kk-bochum.de

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

• Abstract
• Full Text
• References
• PDF

Abstract

The treatment of stroke caused by intracranial vessel occlusion with intravenous recombinant tissue plasminogen activator (rt-PA) was the only evidence-based treatment option for a long time. Nevertheless the response rate was disappointing in large vessel occlusions. Five studies that evaluated the efficacy of mechanical thrombectomy published in 2015 proved a significant clinical benefit for selected patients suffering from acute ischemic stroke. These results are the basis for extensive technical, institutional, and personal structural changes in the neurovascular field of stroke treatment. This review gives an overview of the current status of mechanical thrombectomy and future expectations and challenges are discussed.